352 related articles for article (PubMed ID: 16911491)
1. Incidence, etiology, and risk factors for liver dysfunction in children following hematopoietic stem cell transplantation.
Subbarao G; Haut PR; Johnson CS; Gowan D; Molleston JP
Pediatr Transplant; 2006 Sep; 10(6):682-9. PubMed ID: 16911491
[TBL] [Abstract][Full Text] [Related]
2. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation.
Diaz MA; Vicent MG; Prudencio M; Rodriguez F; Marin C; Serrano A; Sevilla J; Casado J; Madero L
Haematologica; 2002 Mar; 87(3):292-8. PubMed ID: 11869942
[TBL] [Abstract][Full Text] [Related]
3. Abnormal liver enzymes two years after haematopoietic stem cell transplantation in children: prevalence and risk factors.
Bresters D; Van Gils IC; Dekker FW; Lankester AC; Bredius RG; Schweizer JJ
Bone Marrow Transplant; 2008 Jan; 41(1):27-31. PubMed ID: 17994124
[TBL] [Abstract][Full Text] [Related]
4. Risk factors associated with liver injury and impact of liver injury on transplantation-related mortality in pediatric recipients of allogeneic hematopoietic stem cell transplantation.
Radhakrishnan K; Bishop J; Jin Z; Kothari K; Bhatia M; George D; Garvin JH; Martinez M; Ovchinsky N; Lobritto S; Elsayed Y; Satwani P
Biol Blood Marrow Transplant; 2013 Jun; 19(6):912-7. PubMed ID: 23467127
[TBL] [Abstract][Full Text] [Related]
5. Achievement of target cyclosporine concentrations as a predictor of severe acute graft versus host disease in children undergoing hematopoietic stem cell transplantation and receiving cyclosporine and methotrexate prophylaxis.
Punnett A; Sung L; Price V; Das P; Diezi M; Doyle J; Dupuis LL
Ther Drug Monit; 2007 Dec; 29(6):750-7. PubMed ID: 18043472
[TBL] [Abstract][Full Text] [Related]
6. Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation.
Kersting S; Hené RJ; Koomans HA; Verdonck LF
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1169-75. PubMed ID: 17889353
[TBL] [Abstract][Full Text] [Related]
7. Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children.
Schneider DT; Lemburg P; Sprock I; Heying R; Göbel U; Nürnberger W
Bone Marrow Transplant; 2000 May; 25(10):1079-86. PubMed ID: 10828869
[TBL] [Abstract][Full Text] [Related]
8. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
[TBL] [Abstract][Full Text] [Related]
9. Time-course and risk factors of hypothyroidism following allogeneic hematopoietic stem cell transplantation (HSCT) in children conditioned with fractionated total body irradiation.
Bailey HK; Kappy MS; Giller RH; Gralla J
Pediatr Blood Cancer; 2008 Sep; 51(3):405-9. PubMed ID: 18523993
[TBL] [Abstract][Full Text] [Related]
10. Decreasing mortality rate in early pneumonia following hematopoietic stem cell transplantation.
Forslöw U; Mattsson J; Ringden O; Klominek J; Remberger M
Scand J Infect Dis; 2006; 38(11-12):970-6. PubMed ID: 17148063
[TBL] [Abstract][Full Text] [Related]
11. [The effect of hepatitis B virus infection on the outcome of hematopoietic stem cell transplantation].
Du H; Wang M; Yang DL; Huang Y; Han MZ
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Apr; 29(4):387-91. PubMed ID: 18844000
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.
Ruhl CE; Everhart JE
Gastroenterology; 2009 Feb; 136(2):477-85.e11. PubMed ID: 19100265
[TBL] [Abstract][Full Text] [Related]
13. Late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in children.
Kondo M; Kojima S; Kato K; Matsuyama T
Bone Marrow Transplant; 1998 Nov; 22(10):995-8. PubMed ID: 9849697
[TBL] [Abstract][Full Text] [Related]
14. Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning.
Yoshihara S; Tateishi U; Ando T; Kunitoh H; Suyama H; Onishi Y; Tanosaki R; Mineishi S
Bone Marrow Transplant; 2005 Jun; 35(12):1195-200. PubMed ID: 15852024
[TBL] [Abstract][Full Text] [Related]
15. Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients.
Almyroudis NG; Fuller A; Jakubowski A; Sepkowitz K; Jaffe D; Small TN; Kiehn TE; Pamer E; Papanicolaou GA
Transpl Infect Dis; 2005 Mar; 7(1):11-7. PubMed ID: 15984943
[TBL] [Abstract][Full Text] [Related]
16. Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients.
Schmid I; Stachel D; Pagel P; Albert MH
Biol Blood Marrow Transplant; 2008 Apr; 14(4):438-44. PubMed ID: 18342786
[TBL] [Abstract][Full Text] [Related]
17. [Liver complications associated with short-term parenteral nutrition in children].
Moreno Villares JM; Gomis Muñoz P; Galiano Segovia MJ; Valero Zanuy MA; Serrano Garrote O; León Sanz M
An Esp Pediatr; 1999 Jul; 51(1):22-6. PubMed ID: 10452141
[TBL] [Abstract][Full Text] [Related]
18. Serum cholestasis markers as predictors of early outcome after liver transplantation.
Ben-Ari Z; Weiss-Schmilovitz H; Sulkes J; Brown M; Bar-Nathan N; Shaharabani E; Yussim A; Shapira Z; Tur-Kaspa R; Mor E
Clin Transplant; 2004 Apr; 18(2):130-6. PubMed ID: 15016125
[TBL] [Abstract][Full Text] [Related]
19. Ocular findings after allogeneic hematopoietic stem cell transplantation.
Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
[TBL] [Abstract][Full Text] [Related]
20. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.
Cohen A; Rovelli A; Merlo DF; van Lint MT; Lanino E; Bresters D; Ceppi M; Bocchini V; Tichelli A; Socié G
J Clin Oncol; 2007 Jun; 25(17):2449-54. PubMed ID: 17557958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
